Correlation Between Aerovate Therapeutics and 632525BB6

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 632525BB6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 632525BB6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and NAB 3347 12 JAN 37, you can compare the effects of market volatilities on Aerovate Therapeutics and 632525BB6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 632525BB6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 632525BB6.

Diversification Opportunities for Aerovate Therapeutics and 632525BB6

0.81

Correlation Coefficient

Aerovate Therapeutics  632525BB6

Very poor diversification

The 3 months correlation between Aerovate and 632525BB6 is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and NAB 3347 12 JAN 37 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAB 3347 12 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 632525BB6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAB 3347 12 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 632525BB6 go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 632525BB6

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 2.52 times more return on investment than 632525BB6. However, Aerovate Therapeutics is 2.52 times more volatile than NAB 3347 12 JAN 37. It trades about 0.15 of its potential returns per unit of risk. NAB 3347 12 JAN 37 is currently generating about -0.13 per unit of risk. If you would invest  189.00  in Aerovate Therapeutics on September 22, 2024 and sell it today you would earn a total of  64.00  from holding Aerovate Therapeutics or generate 33.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	34.38%
Values	Daily Returns

Aerovate Therapeutics  vs.  NAB 3347 12 JAN 37

Aerovate Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

NAB 3347 12

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NAB 3347 12 JAN 37 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NAB 3347 12 JAN 37 investors.

Pair Trading with Aerovate Therapeutics and 632525BB6

The main advantage of trading using opposite Aerovate Therapeutics and 632525BB6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 632525BB6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 632525BB6 will offset losses from the drop in 632525BB6's long position.

The idea behind Aerovate Therapeutics and NAB 3347 12 JAN 37 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.